![]() |
![]() |
| Anim Biosci > Volume 39(1); 2026 > Article |
|
AUTHORS’ CONTRIBUTION
Conceptualization: Yu YH, Li YH.
Data curation: Yu YH, Chen SB, Wang HT, Li YH.
Formal analysis: Yu YH, Chen SB, Wang HT, Lin CS, Dybus A, Hukowska-Szematowicz B.
Methodology: Yu YH, Chen SB, Wang HT, Li YH.
Validation: Yu YH, Li YH.
Investigation: Yu YH, Chen SB, Wang HT, Lin CS, Dybus A, Hukowska-Szematowicz B.
Writing - original draft: Yu YH.
Writing - review & editing: Yu YH, Chen SB, Wang HT, Lin CS, Dybus A, Hukowska-Szematowicz B, Li YH.
ACKNOWLEDGMENTS
We are grateful to all the laboratory members for their technical advice and helpful discussions.
DATA AVAILABILITY
Upon reasonable request, the datasets of this study can be available from the corresponding author.
| Item | H1) | M | L | |||
|---|---|---|---|---|---|---|
|
|
||||||
| 1–14 d | 15–28 d | 1–14 d | 15–28 d | 1–14 d | 15–28 d | |
| Ingredient (%) | ||||||
| Corn, yellow, 6.9% CP | 57.9 | 63.07 | 59.51 | 66.11 | 63.41 | 68.76 |
| Soybean meal, 43% CP | 23.0 | 20.2 | 21.5 | 16.6 | 17.0 | 16.0 |
| Fish meal, 63% CP | 10.0 | 8.0 | 8.0 | 7.0 | 7.0 | 4.0 |
| Dried whey, 13% CP | 4.4 | 4.0 | 4.0 | 3.5 | 3.5 | 3.5 |
| Soybean oil | 4.0 | 3.6 | 4.45 | 4.15 | 5.0 | 4.2 |
| CaCO3, 38% Ca | 0 | 0 | 0.86 | 0.85 | 1.72 | 1.32 |
| CaHPO4 | 0 | 0 | 0.31 | 0.35 | 0.66 | 0.44 |
| Salt | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
| Choline, 50% | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 |
| Vitamin, premix2) | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Mineral, premix3) | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Lysine, 99% | 0.24 | 0.27 | 0.38 | 0.43 | 0.56 | 0.60 |
| Methionine | 0.11 | 0.11 | 0.15 | 0.14 | 0.18 | 0.20 |
| Threonine | 0.13 | 0.13 | 0.20 | 0.22 | 0.30 | 0.31 |
| Tryptophan | 0 | 0 | 0.02 | 0.03 | 0.05 | 0.05 |
| Chemical composition (%)4) | ||||||
| Crude protein | 20.0 | 18.1 | 18.0 | 15.9 | 15.9 | 14.2 |
| Calcium | 2.9 | 2.57 | 2.9 | 2.57 | 2.9 | 2.57 |
| Phosphorus | 3.3 | 2.99 | 3.3 | 2.99 | 3.3 | 2.99 |
| Lysine | 1.54 | 1.41 | 1.54 | 1.41 | 1.54 | 1.41 |
| Methionine | 0.45 | 0.41 | 0.45 | 0.41 | 0.45 | 0.41 |
| Threonine | 0.96 | 0.88 | 0.96 | 0.88 | 0.96 | 0.88 |
| Tryptophan | 0.27 | 0.25 | 0.27 | 0.25 | 0.27 | 0.25 |
| Isoleucine | 0.91 | 0.81 | 0.83 | 0.71 | 0.71 | 0.61 |
| Histidine | 0.49 | 0.44 | 0.45 | 0.40 | 0.40 | 0.35 |
| Phenyalanine | 0.95 | 0.86 | 0.88 | 0.76 | 0.76 | 0.68 |
| Leucine | 1.86 | 1.70 | 1.72 | 1.53 | 1.53 | 1.38 |
| Valine | 1.14 | 1.02 | 1.04 | 0.90 | 0.90 | 0.78 |
| Aspartic acid | 2.07 | 1.84 | 1.89 | 1.61 | 1.62 | 1.41 |
| Serine | 0.86 | 0.77 | 0.79 | 0.68 | 0.69 | 0.61 |
| Glutamic acid | 3.29 | 3.02 | 3.06 | 2.70 | 2.07 | 2.45 |
| Proline | 1.26 | 1.17 | 1.18 | 1.06 | 1.05 | 0.98 |
| Glycine | 1.03 | 0.91 | 0.92 | 0.80 | 0.80 | 0.66 |
| Alanine | 1.13 | 1.02 | 1.03 | 0.92 | 0.92 | 0.80 |
| Cysteine | 0.15 | 0.13 | 0.13 | 0.11 | 0.11 | 0.10 |
| Tyrosine | 0.59 | 0.53 | 0.54 | 0.47 | 0.47 | 0.41 |
| Arginine | 1.28 | 1.14 | 1.17 | 1.01 | 1.01 | 0.88 |
| ME (kcal/kg) | 3,400 | 3,400 | 3,400 | 3,400 | 3,400 | 3,400 |
1) H: supplementation of 20% crude protein (CP) in the early phase (1–14 days) and 18% CP in the late phase (15–28 days); M: supplementation of 18% CP in the early phase and 16% CP in the late phase; L: supplementation of 16% CP in the early phase and 14% CP in the late phase.
2) Vitamin premix provided the following (per kilogram of diet): 6,000 IU of vitamin A; 900 IU of vitamin D3; 30 IU of vitamin E; 3 mg of menadione (to provide vitamin K); 6 mg of riboflavin; 18 mg of d-pantothenic acid; 60 mg of niacin; and 0.03 mg of vitamin B12.
| H1) | M | L | SEM | p-value | |
|---|---|---|---|---|---|
| Body weight (kg/head) | |||||
| 1 d | 7.62) | 7.6 | 7.6 | 0.01 | 0.990 |
| 28 d | 16.0a | 16.4a | 14.6b | 0.29 | 0.008 |
| Average daily gain (kg/d/head) | |||||
| 1–14 d | 0.19 | 0.18 | 0.14 | 0.01 | 0.058 |
| 15–28 d | 0.41ab | 0.45a | 0.36b | 0.02 | 0.014 |
| 1–28 d | 0.30a | 0.31a | 0.25b | 0.01 | 0.008 |
| Average daily feed intake (kg/d/head) | |||||
| 1–14 d | 0.37 | 0.36 | 0.35 | 0.01 | 0.483 |
| 15–28 d | 0.63 | 0.67 | 0.58 | 0.02 | 0.168 |
| 1–28 d | 0.50 | 0.51 | 0.47 | 0.01 | 0.222 |
| Feed conversion ratio | |||||
| 1–14 d | 1.9b | 2.1ab | 2.5a | 0.11 | 0.046 |
| 15–28 d | 1.6 | 1.5 | 1.6 | 0.04 | 0.282 |
| 1–28 d | 1.7b | 1.6b | 1.9a | 0.04 | 0.010 |
| Mortality (%) | |||||
| 1–28 d | 3.1 | 9.4 | 9.4 | 2.41 | 0.519 |
| Fecal score | |||||
| 1–14 d | 2.5 | 2.4 | 2.2 | 0.07 | 0.081 |
| 15–28 d | 2.6 | 2.2 | 2.2 | 0.08 | 0.123 |
| 1–28 d | 2.6 | 2.3 | 2.2 | 0.07 | 0.108 |
| Diarrhea incidence (%) | |||||
| 1–14 d | 21.9 | 22.0 | 13.8 | 2.60 | 0.371 |
| 15–28 d | 19.9 | 16.5 | 19.5 | 2.43 | 0.853 |
| 1–28 d | 20.9 | 19.3 | 16.7 | 2.06 | 0.740 |
| H1) | M | L | SEM | p-value | |
|---|---|---|---|---|---|
| Glucose (mg/dL) | 105.52) | 93.9 | 98.3 | 3.32 | 0.388 |
| Triglyceride (mg/dL) | 50.25 | 65.1 | 63.8 | 3.43 | 0.147 |
| Cholesterol (mg/dL) | 74.5 | 77.3 | 76.8 | 1.37 | 0.723 |
| High-density lipoprotein (mg/dL) | 25.4 | 26.9 | 26.4 | 0.88 | 0.809 |
| Low-density lipoprotein (mg/dL) | 33.5 | 35.3 | 34.6 | 1.08 | 0.828 |
| Aspartate transaminase (U/L) | 85.0a | 75.3ab | 65.5b | 3.15 | 0.020 |
| Alanine aminotransferase (U/L) | 63.8 | 66.9 | 61.4 | 2.91 | 0.777 |
| Alkaline phosphatase (U/L) | 217.6 | 211.0 | 205.4 | 11.97 | 0.930 |
| Total protein (g/dL) | 5.4 | 5.4 | 5.3 | 0.09 | 0.946 |
| Albumin (g/dL) | 3.0 | 3.0 | 2.9 | 0.04 | 0.620 |
| Globulin (g/dL) | 2.4 | 2.4 | 2.4 | 0.09 | 0.975 |
| Blood urea nitrogen (mg/dL) | 6.1a | 4.2ab | 3.4b | 0.47 | 0.032 |
| Creatinine (mg/dL) | 0.9 | 0.9 | 0.8 | 0.02 | 0.286 |
| Cortisol (μg/dL) | 3.6a | 2.0ab | 0.9b | 0.42 | 0.007 |
| H1) | M | L | SEM | p-value | ||
|---|---|---|---|---|---|---|
| Duodenum | Villus height (μm) | 452.52),ab | 521.7a | 379.7b | 20.73 | 0.004 |
| Crypt depth (μm) | 314.4 | 310.6 | 375.3 | 13.55 | 0.077 | |
| Villus height: Crypt depth | 1.5a | 1.8a | 1.0b | 0.10 | <0.001 | |
| Jejunum | Villus height (μm) | 427.2ab | 475.0a | 363.3b | 16.25 | 0.003 |
| Crypt depth (μm) | 279.2 | 255.8 | 300.0 | 10.84 | 0.271 | |
| Villus height: Crypt depth | 1.7 | 2.1 | 1.3 | 0.17 | 0.140 | |
| Ileum | Villus height (μm) | 394.4 | 395.3 | 325.8 | 14.79 | 0.074 |
| Crypt depth (μm) | 247.5 | 219.4 | 261.1 | 9.38 | 0.187 | |
| Villus height: Crypt depth | 1.7a | 1.9a | 1.3b | 0.08 | 0.003 |
| Regulation | Ensemble gene ID | Gene symbol | Description | Fold change | p-value1) | |
|---|---|---|---|---|---|---|
| M versus H2) | Up | 00000003494 | PLA2G2A | Phospholipase A2 group IIA | 10.1 | <0.001 |
| 00000037260 | Unknown | Unknown | 5.6 | <0.001 | ||
| 00000050531 | Unknown | Unknown | 3.8 | <0.001 | ||
| 00000037823 | ANKRD34A | Ankyrin repeat domain 34A | 3.8 | 0.002 | ||
| 00000049869 | Unknown | Unknown | 3.6 | 0.021 | ||
| 00000007488 | DOK5 | Docking protein 5 | 3.6 | 0.019 | ||
| 00000032588 | C3orf85 | Chromosome 3 open reading frame 85 | 3.3 | <0.001 | ||
| 00000051144 | Unknown | Unknown | 3.1 | 0.001 | ||
| 00000046357 | Unknown | Unknown | 3.1 | 0.022 | ||
| 00000011217 | NEK10 | NIMA related kinase 10 | 3.1 | 0.046 | ||
| Down | 00000008615 | VSNL1 | Visinin like 1 | −7.2 | <0.001 | |
| 00000015979 | HOXD13 | Homeobox D13 | −7.0 | <0.001 | ||
| 00000021938 | UPP2 | Uridine phosphorylase 2 | −5.2 | 0.001 | ||
| 00000049086 | Unknown | Unknown | −5.1 | <0.001 | ||
| 00000035066 | MYOC | Myocilin | −4.8 | <0.001 | ||
| 00000013060 | SCGB1A1 | Secretoglobin family 1A member 1 | −4.5 | 0.002 | ||
| 00000032826 | KCTD16 | Potassium channel tetramerization domain containing 16 | −4.4 | 0.003 | ||
| 00000000871 | SLC5A8 | Solute carrier family 5 member 8 | −4.2 | <0.001 | ||
| 00000038785 | CA7 | Carbonic anhydrase 7 | −4.1 | <0.001 | ||
| 00000047906 | Unknown | Unknown | −3.9 | <0.001 | ||
| L versus H | Up | 00000032588 | C3orf85 | Chromosome 3 open reading frame 85 | 3.4 | <0.001 |
| 00000046777 | Unknown | Unknown | 2.4 | <0.001 | ||
| 00000042459 | Unknown | Unknown | 2.2 | <0.001 | ||
| 00000049575 | Unknown | Unknown | 2.2 | <0.001 | ||
| 00000011735 | SI | Sucrase–isomaltase | 2.0 | 0.009 | ||
| 00000039341 | Unknown | Unknown | 1.9 | <0.001 | ||
| 00000028627 | Unknown | Unknown | 1.9 | <0.001 | ||
| 00000001473 | COL11A2 | Collagen type XI alpha 2 chain | 1.9 | 0.004 | ||
| 00000047669 | Unknown | Unknown | 1.9 | 0.002 | ||
| 00000023607 | CYP4F22 | Cytochrome P450 family 4 subfamily F member 22 | 1.8 | <0.001 | ||
| Down | 00000015979 | HOXD13 | Homeobox D13 | −6.8 | <0.001 | |
| 00000008615 | VSNL1 | Visinin like 1 | −5.5 | <0.001 | ||
| 00000045751 | Unknown | Unknown | −3.7 | <0.001 | ||
| 00000039573 | SLPI | Secretory leukocyte peptidase inhibitor | −3.7 | <0.001 | ||
| 00000038785 | CA7 | Carbonic anhydrase 7 | −3.4 | <0.001 | ||
| 00000009561 | ATP4B | Potassium-transporting ATPase subunit beta | −3.0 | <0.001 | ||
| 00000033015 | B3GNT7 | betaGal beta-1,3-N-acetylglucosaminyltransferase 7 | −2.9 | <0.001 | ||
| 00000028758 | LBP | Lipopolysaccharide-binding protein | −2.9 | <0.001 | ||
| 00000007384 | WFDC5 | WAP four-disulfide core domain 5 | −2.9 | <0.001 | ||
| 00000035066 | MYOC | Myocilin | −2.8 | <0.001 |
| Regulation | Pathway | p-value1) | |
|---|---|---|---|
| M versus H2) | Up | Cytoskeleton in muscle cells | <0.001 |
| cAMP signaling pathway | <0.001 | ||
| Neuroactive ligand–receptor interaction | <0.001 | ||
| Calcium signaling pathway | <0.001 | ||
| Adrenergic signaling in cardiomyocytes | <0.001 | ||
| Motor proteins | <0.001 | ||
| Vascular smooth muscle contraction | <0.001 | ||
| Cardiac muscle contraction | <0.001 | ||
| Axon guidance | 0.002 | ||
| Nicotine addiction | 0.006 | ||
| Dilated cardiomyopathy | 0.016 | ||
| Glutamatergic synapse | 0.025 | ||
| Insulin secretion | 0.025 | ||
| Circadian entrainment | 0.047 | ||
| Hypertrophic cardiomyopathy | 0.047 | ||
| Down | IL-17 signaling pathway | 0.027 | |
| Cytosolic DNA-sensing pathway | 0.043 | ||
| TNF signaling pathway | 0.043 | ||
| Hematopoietic cell lineage | 0.048 | ||
| L versus H | Up | Retinol metabolism | <0.001 |
| Nitrogen metabolism | <0.001 | ||
| Drug metabolism - cytochrome P450 | <0.001 | ||
| Metabolism of xenobiotics by cytochrome P450 | <0.001 | ||
| Steroid hormone biosynthesis | <0.001 | ||
| Bile secretion | 0.001 | ||
| Ascorbate and aldarate metabolism | 0.019 | ||
| Pentose and glucuronate interconversions | 0.019 | ||
| Tyrosine metabolism | 0.032 | ||
| Porphyrin metabolism | 0.032 | ||
| Glycine, serine and threonine metabolism | 0.032 | ||
| Fatty acid degradation | 0.032 | ||
| Pyruvate metabolism | 0.032 | ||
| Arginine and proline metabolism | 0.040 | ||
| Chemical carcinogenesis - DNA adducts | 0.049 | ||
| Down | IL-17 signaling pathway | <0.001 | |
| PPAR signaling pathway | 0.034 |
| H1) | M | L | SEM | p-value | |||
|---|---|---|---|---|---|---|---|
|
|
|||||||
| H vs. M | M vs. L | L vs. H | |||||
| Phylum | |||||||
| Firmicutes | 90.62) | 83.9 | 88.1 | 1.87 | 0.239 | 0.378 | 0.769 |
| Bacteroidota | 6.3 | 11.4 | 8.9 | 1.41 | 0.170 | 0.695 | 0.163 |
| Family | |||||||
| Lactobacillaceae | 52.4 | 40.7 | 39.4 | 2.62 | 0.141 | 0.769 | 0.078 |
| Veillonellaceae | 7.3 | 11.9 | 11.4 | 0.90 | 0.019 | 1.000 | 0.019 |
| Streptococcaceae | 11.2 | 7.9 | 11.5 | 1.17 | 0.239 | 0.239 | 1.000 |
| Lachnospiraceae | 8.5 | 9.6 | 11.9 | 0.61 | 0.493 | 0.202 | 0.050 |
| Prevotellaceae | 5.8 | 10.8 | 8.8 | 1.36 | 0.239 | 0.769 | 0.378 |
| Oscillospiraceae | 3.9 | 4.3 | 4.4 | 0.27 | 0.556 | 0.769 | 0.769 |
| Genus | |||||||
| Lactobacillus | 38.3 | 33.7 | 30.9 | 1.65 | 0.433 | 0.433 | 0.117 |
| Streptococcus | 11.2 | 7.9 | 11.5 | 1.17 | 0.239 | 0.239 | 1.000 |
| Limosilactobacillus | 13.7 | 6.2 | 8.2 | 1.18 | 0.008 | 0.378 | 0.078 |
| Megasphaera | 6.3 | 10.2 | 9.9 | 0.85 | 0.019 | 1.000 | 0.019 |
| Prevotella | 4.4 | 8.2 | 7.1 | 1.04 | 0.117 | 0.845 | 0.170 |
| Blautia | 1.6 | 2.6 | 3.1 | 0.23 | 0.050 | 0.433 | 0.006 |
| Campylobacter | 2.1 | 2.0 | 1.7 | 0.37 | 0.695 | 0.695 | 0.433 |
| Selenomonas | 1.2 | 2.2 | 1.7 | 0.29 | 0.117 | 0.433 | 0.433 |
| Eubacterium | 1.5 | 1.2 | 2.1 | 0.25 | 0.767 | 0.239 | 0.378 |
| Prevotellamassilia | 1.2 | 2.3 | 1.2 | 0.38 | 0.096 | 0.493 | 0.327 |
| Species | |||||||
| Lactobacillus johnsonii | 25.2 | 6.4 | 22.6 | 2.73 | 0.011 | 0.031 | 0.695 |
| Lactobacillus amylovorus DSM 20531 | 11.1 | 25.0 | 6.9 | 2.73 | 0.050 | 0.006 | 0.433 |
| Streptococcus alactolyticus | 11.1 | 6.2 | 10.8 | 1.28 | 0.050 | 0.117 | 0.695 |
| Megasphaera elsdenii DSM 20460 | 6.3 | 10.2 | 9.8 | 0.85 | 0.019 | 1.000 | 0.019 |
| Limosilactobacillus reuteri subsp. reuteri | 11.7 | 4.1 | 7.4 | 1.05 | 0.003 | 0.239 | 0.078 |
| Prevotella copri DSM 18205 | 1.9 | 3.9 | 3.0 | 0.48 | 0.062 | 0.281 | 0.433 |
| Campylobacter lanienae NCTC 13004 | 2.1 | 2.0 | 1.7 | 0.37 | 0.695 | 0.695 | 0.433 |
| Prevotella hominis | 1.3 | 1.9 | 2.1 | 0.27 | 0.327 | 0.922 | 0.281 |
| Selenomonas bovis | 1.2 | 2.2 | 1.7 | 0.29 | 0.117 | 0.433 | 0.433 |
| [Eubacterium] rectale ATCC 33656 | 1.5 | 1.2 | 2.1 | 0.25 | 0.769 | 0.239 | 0.378 |
| Prevotellamassilia timonensis | 1.2 | 2.3 | 1.2 | 0.38 | 0.096 | 0.327 | 0.493 |
| Mitsuokella jalaludinii | 0.4 | 1.3 | 2.5 | 0.34 | 0.078 | 0.239 | 0.003 |
| Limosilactobacillus mucosae | 1.8 | 1.6 | 0.7 | 0.27 | 0.845 | 0.062 | 0.096 |
| Blautia luti DSM 14534 | 0.7 | 1.5 | 1.7 | 0.16 | 0.019 | 1.000 | 0.019 |
| Dialister succinatiphilus YIT 11850 | 0.9 | 1.5 | 1.3 | 0.10 | 0.039 | 0.769 | 0.078 |

![]() |
![]() |